MERRIMACK PHARMACEUTICALS INC — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/377568b9-419f-4be0-b92b-464dac3753e1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $53.1M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003026 |
| FY 2015 | $89.3M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-480919 |
| FY 2014 | $92.3M | 2014-01-01 – 2014-12-31 | evidence 0000950123-17-011384 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001193125-16-480919 |
| FY 2012 | $48.9M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-003118 |
| FY 2011 | $34.2M | 2011-01-01 – 2011-12-31 | evidence 0001047469-13-003118 |
| FY 2010 | $20.3M | 2010-01-01 – 2010-12-31 | evidence 0001047469-13-003118 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MERRIMACK PHARMACEUTICALS INC — all facts · Net Income · Operating Income